| Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. | liver, |
| There is a double-negative feedback loop between a tumor suppressor (miR-122) and an oncogene (c-Myc) in hepatocellular cancer. | liver, |
| Metformin targets c-MYC oncogene to prevent prostate cancer. | prostate, |
| Acidosis decreases c-Myc oncogene expression in human lymphoma cells: a role for the proton-sensing G protein-coupled receptor TDAG8. | lymphoma, |
| Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. | neuroblastoma, |
| c-myc oncogene alterations in human thyroid carcinomas. | thyroid, |
| In conclusion, the development of colorectal cancer requires MYC activation through retention of the risk allele, or amplification of the non-risk allele at the oncogenic single nucleotide polymorphism. | colorectal, |
| Allelic imbalance at an 8q24 oncogenic SNP is involved in activating MYC in human colorectal cancer. | colorectal, |
| High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma. | neuroblastoma, |
| Data suggest GHET1 (gastric carcinoma high expressed transcript 1) is prognostic factor for gastric carcinoma; GHET1 promotes c-Myc (proto-oncogene proteins c-Myc) mRNA stability/expression, binds IGF2BP1, and promotes gastric carcinoma growth. | gastric, |
| Data suggest a shared underlying biology among proto-oncogene proteins myc rearranged B-cell lymphomas. | lymphoma, |
| Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. | gastric, |
| conclude that downregulation of BIM represents a key survival signal downstream of oncogenic MYC and PI3K-AKT signaling in treatment-resistantT-cell acute lymphoblastic leukemia | leukemia, |
| It is a gastric carcinoma oncogene and is targeted by miR-494. | gastric, |
| miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. | gastric, |
| N-myc oncogene RNA expression in neuroblastoma. | neuroblastoma, |
| Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines. | cervical, |
| Our in vitro findings suggest that C-MYC and PVT1 oncogene (non-protein coding) copy number gains may promote a malignant malignant pleural mesothelioma phenotype. | mesothelioma, |
| we observed amplification of the MYC locus in 6/7 and MYC protein overexpression in all cases of undifferentiated round cell sarcomas defined molecularly by oncogenic fusion of the gene, CIC and DUX4 tested | sarcoma, |
| Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation. | prostate, |